The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data

BACKGROUND: Acute T-cell lymphoblastic leukaemia (T-ALL) is an aggressive disorder derived from immature thymocytes. The variability observed in clinical responses on this type of tumours to treatments, the high toxicity of current protocols and the poor prognosis of patients with relapse or refract...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Navarro, Pablo, López-Nieva, Pilar, Piñeiro-Yañez, Elena, Carreño-Tarragona, Gonzalo, Martinez-López, Joaquín, Sánchez Pérez, Raúl, Aroca, Ángel, Al-Shahrour, Fátima, Cobos-Fernández, María Ángeles, Fernández-Piqueras, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815385/
https://www.ncbi.nlm.nih.gov/pubmed/31655559
http://dx.doi.org/10.1186/s12885-019-6209-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815385/
https://www.ncbi.nlm.nih.gov/pubmed/31655559
http://dx.doi.org/10.1186/s12885-019-6209-9

Ejemplares similares